Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant RecipientsCaroline X. Qin, Dorry L. Segev, Nikolina Bašić‐Jukić et al.|Transplantation|2021Cited by 162
Wait Time Advantage for Transplant Candidates With HIV Who Accept Kidneys From Donors With HIV Under the HOPE ActJennifer D. Motter, Sarah Hussain, Diane Brown et al.|Transplantation|2023Cited by 31
National Landscape of Human Immunodeficiency Virus–Positive Deceased Organ Donors in the United StatesWilliam A. Werbel, Jennifer D. Motter, Diane Brown et al.|Clinical Infectious Diseases|2021Cited by 23
Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV resultsChristine M. Durand, William A. Werbel, Brianna Doby et al.|American Journal of Transplantation|2019Cited by 16
Kaposi Sarcoma–Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With HIV in the United StatesPuja H. Nambiar, Christine M. Durand, Tao Liang et al.|Clinical Infectious Diseases|2025Cited by 8